Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CTLA4 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement CTLA4 dans ELISA et in vivo. Il présente une réactivité envers Humain.
N° du produit ABIN7543361

Aperçu rapide pour Recombinant CTLA4 anticorps (ABIN7543361)

Antigène

Voir toutes CTLA4 Anticorps
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 129
  • 87
  • 44
  • 14
  • 3
Humain

Hôte

  • 74
  • 71
  • 24
  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Souris

Clonalité

  • 113
  • 67
  • 3
Monoclonal

Conjugué

  • 85
  • 19
  • 13
  • 13
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CTLA4 est non-conjugé

Application

  • 99
  • 70
  • 61
  • 38
  • 28
  • 20
  • 17
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, In vivo Studies (in vivo)

Clone

5E3
  • Fonction

    Anti-CTLA-4 [5E3], Mouse IgG1, kappa

    Specificité

    The antibody is specific for CTLA-4. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses.

    Attributs du produit

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    The original antibody was generated by immunizing BALB/c mice with CTLA-4 protein.

    Isotype

    IgG1 kappa
  • Indications d'application

    The specificity of the antibody was confirmed by ELISA analysis. The kinetic parameters of human CTLA-4 protein binding to the antibody were measured and they resulted to be at the sub-nm level. The antitumor activity of the humanized antibody was demonstrated in vivo in animal models. It was proved that the antibody inhibited the tumor in a dose-dependent manner. Mouse PD-1 antibody was combined with the antibody and used to evaluate the toxicity to mice, these experiments compared with the use of Ipilimumab in combination with PD-1 antibody. Results showed that after 5E3 antibody was used in combination with PD-1 antibody, the immunity to the body and the toxicity of heart, liver and lung are significantly lower than the toxicity of Ipilimumab in combination with PD-1 antibody (CN110343180).

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Autre désignation

    CTLA-4

    Sujet

    Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!